SCHEDULE 13G/A: Griffin Asset Management Discloses 4.0% Passive Stake in Accelerate Diagnostics
Beneficial Ownership Disclosure
Griffin Asset Management, LLC has filed an amended Schedule 13G, reporting a 4.0% passive beneficial ownership stake in Accelerate Diagnostics, Inc. as of December 31, 2024.
Summary
- Griffin Asset Management, LLC reported beneficial ownership of 1,003,581 shares of Accelerate Diagnostics, Inc. common stock.
- This ownership represents 4.0% of the total class of securities.
- The filing is an Amendment No. 1 to a Schedule 13G, indicating a passive investment position.
- Griffin Asset Management, LLC holds sole voting power and sole dispositive power over all 1,003,581 shares.
- The event date requiring this filing was December 31, 2024, and the filing was signed on January 7, 2025.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information to assess company performance or outlook.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires filing of this statement |
| 01/07/2025 | Signature date of the filing |
Keywords
Accelerate Diagnostics, Griffin Asset Management, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, Passive Investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.